Skip to main content
Clinical Trials/NCT06350500
NCT06350500
Recruiting
N/A

Addressing Disparities in Breast Cancer Care: An Approach to Health Equity

Roswell Park Cancer Institute1 site in 1 country126 target enrollmentDecember 15, 2024

Overview

Phase
N/A
Intervention
Patient Navigation
Conditions
Breast Carcinoma
Sponsor
Roswell Park Cancer Institute
Enrollment
126
Locations
1
Primary Endpoint
Retention Rate
Status
Recruiting
Last Updated
2 months ago

Overview

Brief Summary

This clinical trial evaluates a patient navigation program for addressing disparities in breast cancer care. The navigation program is designed to help improve patient knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance patient skills related to management of cancer treatment. Offering a patient navigation program may increase health equity and improve social needs and quality of life over time for newly diagnosed breast cancer patients.

Detailed Description

PRIMARY OBJECTIVE: I. Implement a patient navigation program in the Roswell Park Breast Clinic focused on underserved women with a first cancer diagnosis of breast cancer or ductal carcinoma in situ (DCIS) (n=126). SECONDARY OBJECTIVE: I. Systematically address barriers to care by connecting women with multiple barriers of care with a first diagnosis of breast cancer or DCIS to supportive services and culturally appropriate resources.

Registry
clinicaltrials.gov
Start Date
December 15, 2024
End Date
March 15, 2028
Last Updated
2 months ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years of age
  • Have a confirmed diagnosis of breast cancer or Ductal Carcinoma In Situ (DCIS)
  • Currently identify their gender as woman or female
  • Was assigned female sex at birth (AFAB)
  • \- Participant is experiencing ≥1 barrier to care as determined by the social needs screening tool
  • Participant must understand the investigational nature of this study and verbally consent to participate prior to receiving any study related intervention

Exclusion Criteria

  • Participants who are not suspected of or diagnosed with breast cancer or Ductal Carcinoma in Situ (DCIS)
  • Participants who have had a previous diagnosis of any cancer
  • Participants who were assigned male sex or intersex at birth
  • Unwilling or unable to follow protocol requirements

Arms & Interventions

Health Services Research (Patient Navigation)

Patients receive patient navigation services from a patient navigator as needed to improve knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance skills related to management of cancer treatment

Intervention: Patient Navigation

Health Services Research (Patient Navigation)

Patients receive patient navigation services from a patient navigator as needed to improve knowledge about clinical and supportive care services, navigate to existing services, help manage barriers to care, and enhance skills related to management of cancer treatment

Intervention: Questionnaire

Outcomes

Primary Outcomes

Retention Rate

Time Frame: Up to 2 years

The number of patients that complete patient navigation divided by the number of patients enrolled

Enrollment rate

Time Frame: Up to 2 years

Enrollment rate Will be defined as the number of patients enrolled divided by the number of patients approached. The enrollment rate will be estimated with a 90% credible region obtained by Jeffrey's prior method.

Reasons for refusal

Time Frame: Up to 2 years

Reported reasons of refusal will be summarized using frequencies and relative frequencies

Reasons for discontinuation

Time Frame: Up to 2 years

Will be summarized using frequencies and relative frequencies

Secondary Outcomes

  • Use of supportive services(Up to 2 years)
  • Social Determinates of health(Up to 2 years)
  • European Organization for Research and Treatment of Cancer Quality of Life Scale (EORTC QLQ-C30)(Up to 2 years)
  • Patient Satisfaction survey(up to 2 years)
  • Barriers to care(Up to 2 years)

Study Sites (1)

Loading locations...

Similar Trials